Neurogene Inc.NGNENASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+13.6%
5Y CAGR+23.4%
Year-over-Year Change
Research and development spending
3Y CAGR
+13.6%/yr
vs +9.7%/yr prior
5Y CAGR
+23.4%/yr
Recent deceleration
Acceleration
+3.9pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.9x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $69.71M | +14.4% |
| 2024 | $60.92M | +37.2% |
| 2023 | $44.39M | -6.5% |
| 2022 | $47.51M | +12.4% |
| 2021 | $42.26M | +73.6% |
| 2020 | $24.34M | +285.4% |
| 2019 | $6.32M | -80.7% |
| 2018 | $32.79M | -9.6% |
| 2017 | $36.27M | +27.8% |
| 2016 | $28.38M | - |